Curi RMB Capital’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-29,881
| Closed | -$348K | – | 529 |
|
|
2024
Q4 | $348K | Sell |
29,881
-9,306
| -24% | -$109K | 0.01% | 445 |
|
|
2024
Q3 | $805K | Buy |
39,187
+4,662
| +14% | +$95.8K | 0.02% | 367 |
|
|
2024
Q2 | $773K | Hold |
34,525
| – | – | 0.02% | 359 |
|
|
2024
Q1 | $950K | Buy |
34,525
+6,465
| +23% | +$178K | 0.02% | 352 |
|
|
2023
Q4 | $856K | Hold |
28,060
| – | – | 0.03% | 314 |
|
|
2023
Q3 | $887K | Buy |
28,060
+4,103
| +17% | +$130K | 0.03% | 289 |
|
|
2023
Q2 | $977K | Hold |
23,957
| – | – | 0.03% | 288 |
|
|
2023
Q1 | $893K | Buy |
23,957
+6,633
| +38% | +$247K | 0.03% | 291 |
|
|
2022
Q4 | $604K | Sell |
17,324
-7,775
| -31% | -$271K | 0.02% | 337 |
|
|
2022
Q3 | $1.41M | Hold |
25,099
| – | – | 0.05% | 255 |
|
|
2022
Q2 | $1.3M | Hold |
25,099
| – | – | 0.04% | 250 |
|
|
2022
Q1 | $1.82M | Buy |
25,099
+4,394
| +21% | +$319K | 0.06% | 203 |
|
|
2021
Q4 | $2.45M | Buy |
20,705
+3,477
| +20% | +$411K | 0.07% | 185 |
|
|
2021
Q3 | $2.31M | Sell |
17,228
-527
| -3% | -$70.7K | 0.08% | 192 |
|
|
2021
Q2 | $2.88M | Hold |
17,755
| – | – | 0.1% | 173 |
|
|
2021
Q1 | $1.43M | Buy |
+17,755
| New | +$1.43M | 0.05% | 219 |
|